共 50 条
- [31] Real-world effectiveness of fidaxomicin in patients at high risk of Clostridioides difficile recurrence ANTIMICROBIAL STEWARDSHIP & HEALTHCARE EPIDEMIOLOGY, 2024, 4 (01):
- [37] Infusion of Bezlotoxumab at the End of an Antibiotic Treatment Course for Prevention of Recurrent Clostridioides difficile Infection AMERICAN JOURNAL OF GASTROENTEROLOGY, 2021, 116 : S82 - S82
- [39] Risk of Clostridioides difficile infection in patients with inflammatory bowel disease JOURNAL OF CROHNS & COLITIS, 2024, 18 : I2044 - I2044